2021
DOI: 10.1097/oi9.0000000000000143
|View full text |Cite
|
Sign up to set email alerts
|

Tranexamic acid administration and pulmonary embolism in combat casualties with orthopaedic injuries

Abstract: Objectives: In combat casualty care, tranexamic acid (TXA) is administered as part of initial resuscitation effort; however, conflicting data exist as to whether TXA contributes to increased risk of venous thromboembolism (VTE). The purpose of this study is to determine what factors increase risk of pulmonary embolism after combat-related orthopaedic trauma and whether administration of TXA is an independent risk factor for major thromboembolic events.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 45 publications
0
8
0
1
Order By: Relevance
“…Consensus on the optimal application of TXA has yet to be developed in academia. Though most scholars proved the availability of TXA for systemic administration, there is a high risk for intravenous injections in elderly patients with comorbid underlying diseases, and there is also a risk of postoperative DVT in patients [ 23 ]. It has been found that the application of TXA in intra-articular cavity injection can further enhance the hemostatic effect because intra-articular TXA targets active bleeding sites and increases the stability of the fibrin clot, thereby avoiding blood loss from the tissue surface [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…Consensus on the optimal application of TXA has yet to be developed in academia. Though most scholars proved the availability of TXA for systemic administration, there is a high risk for intravenous injections in elderly patients with comorbid underlying diseases, and there is also a risk of postoperative DVT in patients [ 23 ]. It has been found that the application of TXA in intra-articular cavity injection can further enhance the hemostatic effect because intra-articular TXA targets active bleeding sites and increases the stability of the fibrin clot, thereby avoiding blood loss from the tissue surface [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…The unaffected brinolytic process inspired an assumption that anti brinolytic agents should not be provided as the rst-line treatment of hypothermia coagulopathy in major thoracic surgeries. Constituent transfusion may be more e cacious [19] and more secure in correcting the cross-links of the coagulation cascade, considering the thrombotic risks carried by anti brinolytic treatments [20].…”
Section: Discussionmentioning
confidence: 99%
“…В руководстве ТССС рекомендуется вводить транексамовую кис лоту на догоспитальном этапе пострадавшим, нуждающимся в переливании крови, в дозе 2 г медленно внутривенно или внутрикостно как возможно раньше, но не позднее чем через 3 ч после травмы [43]. Между тем, послед ние исследования показали, что применение транексамовой кислоты при боевой травме с массивной кровопотерей и скелетными по вреждениями значимо повышает риск веноз ных тромбоэмболических осложнений [21,22]. Рекомендации ТССС в отношении транекса мовой кислоты редко соблюдались во время военных конфликтов в Ираке и Афганистане.…”
Section: результаты и их анализunclassified